Preferred Name |
Entacapone |
|
Synonyms |
Comtan ENTACAPONE Entacapone |
|
Definitions |
A nitrocatechol compound with anti-parkinsonian property. Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), which catalyzes the transfer of the methyl group of S-adenosyl-L-methionine to the phenolic group of substrates that contain a catechol structure including dihydroxyphenylalanine (DOPA), catecholamines (dopamine, norepinephrine, and epinephrine) and their hydroxylated metabolites. When administered in conjunction with dopaminergic agents such as L-DOPA, entacapone prevents the metabolism and inactivation of adjunct drugs, thereby increasing the bioavailability of these compounds by facilitating their passage across the blood-brain barrier. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61746 |
|
CAS_Registry |
130929-57-6 |
|
CHEBI_ID |
CHEBI:4798 |
|
Chemical_Formula |
C14H15N3O5 |
|
code |
C61746 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A nitrocatechol compound with anti-parkinsonian property. Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), which catalyzes the transfer of the methyl group of S-adenosyl-L-methionine to the phenolic group of substrates that contain a catechol structure including dihydroxyphenylalanine (DOPA), catecholamines (dopamine, norepinephrine, and epinephrine) and their hydroxylated metabolites. When administered in conjunction with dopaminergic agents such as L-DOPA, entacapone prevents the metabolism and inactivation of adjunct drugs, thereby increasing the bioavailability of these compounds by facilitating their passage across the blood-brain barrier. |
|
FDA_UNII_Code |
4975G9NM6T |
|
FULL_SYN |
Comtan ENTACAPONE Entacapone |
|
label |
Entacapone |
|
Legacy Concept Name |
Entacapone |
|
NCI_Drug_Dictionary_ID |
801668 |
|
PDQ_Closed_Trial_Search_ID |
801668 |
|
PDQ_Open_Trial_Search_ID |
801668 |
|
Preferred_Name |
Entacapone |
|
prefixIRI |
Thesaurus:C61746 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0876730 |
|
subClassOf |